Structural significance of azaheterocyclic amines related to Parkinson's disease for dopamine transporter

Author： Matsubara K.   Senda T.   Uezono T.   Fukushima S.   Ohta S.   Igarashi K.   Naoi M.   Yamashita Y.   Ohtaki K.-i.   Hayase N.   Akutsu S.   Kimura K.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.348, Iss.1, 1998-05, pp. : 77-84

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dopamine agonists in Parkinson’s disease

By Tintner Ron   Jankovic Joseph  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 11, 2003-11 ,pp. : 1803-1820

Informa Healthcare

Access to resources Recommend Favorite

Action of -phenylethylamine and related amines on nigrostriatal dopamine neurotransmission

By Barroso N.   Rodriguez M.  

European Journal of Pharmacology, Vol. 297, Iss. 3, 1996-02 ,pp. : 195-203

Elsevier

Access to resources Recommend Favorite

Clinical Pharmacology of Dopamine Agonists in Parkinson's Disease

By Lange K.W.  

Drugs & Aging, Vol. 13, Iss. 5, 1998-11 ,pp. : 381-389

Adis International

Access to resources Recommend Favorite

The safety of dopamine agonists in the treatment of Parkinson's disease

By Bonuccelli Ubaldo   Ceravolo Roberto  

Expert Opinion on Drug Safety, Vol. 7, Iss. 2, 2008-03 ,pp. : 111-127

Informa Healthcare

Access to resources Recommend Favorite

Nitric Oxide and Dopamine Neurons. Implications for Parkinson's Disease

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 5, Iss. 3, 2005-09 ,pp. : 193-205

Bentham Science Publishers

Access to resources Recommend Favorite